Condition
Hypopharyngeal Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Hypopharyngeal Cancer clinical trials that are recruiting, at sites in 4 countries (most in United States (2), China (2), Switzerland (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Hypopharyngeal Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Docetaxel and SX-682 in head and neck cancers and prostate cancer | Phase 1/2 | Bethesda, Maryland | Recruiting | Jun 25, 2026 |
| Machine learning helps predict head and neck cancer risk from patient data and images | — | Nanjing, Jiangsu | Recruiting | Apr 16, 2026 |
| Neoadjuvant treatment for laryngeal and hypopharyngeal cancer | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Sep 15, 2023 |
| Using voice recordings to monitor laryngeal and hypopharyngeal cancer recurrence | — | Bern and 1 other locations | Recruiting | Jun 8, 2023 |
| Study of immune biomarkers in head and neck cancer | — | Erlangen, Bavaria and 2 other locations | Recruiting | May 16, 2022 |
| A resource for collecting cancer data and biospecimens | — | Greenwood Village, Colorado and 41 other locations | Recruiting | Dec 16, 2013 |
All recruiting trials (6)
-
Docetaxel and SX-682 in head and neck cancers and prostate cancer
This trial tests a new drug SX-682 together with docetaxel in adults whose head and neck cancers or prostate cancer have returned or spread.
-
Machine learning helps predict head and neck cancer risk from patient data and images
Researchers are testing a deep learning model to see if AI can predict the risk of head and neck cancer in adults using clinical data and laryngoscopic images.
-
Neoadjuvant treatment for laryngeal and hypopharyngeal cancer
This study is testing a new treatment that combines immunotherapy and chemotherapy before surgery or radiation to see if it helps people with advanced laryngeal or hypopharyngeal cancer live better and longer while keeping their voice.
-
Using voice recordings to monitor laryngeal and hypopharyngeal cancer recurrence
This study is testing if regular voice recordings can help keep track of cancer returning in patients who have finished treatment for laryngeal and hypopharyngeal cancer.
-
Study of immune biomarkers in head and neck cancer
This study is testing if certain immune markers in patients with newly diagnosed head and neck cancer can help predict their treatment outcomes and guide their care.
-
A resource for collecting cancer data and biospecimens
This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.
Related topics
Quick answers
How many Hypopharyngeal Cancer clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), China (2 trials), Switzerland (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.